Evidence map›Paper›PMID 35107622›Full record

ReviewCell and tissue research2023

Cell biology of prion strains in vivo and in vitro.

Daniel Shoup, Suzette A Priola

Open access · greenAbstract readReview
In one paragraph

Review in Cell and tissue research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Mechanisms of prion-induced toxicity.Cell and tissue research · 2023
    Review
  4. New developments in prion disease research.Cell and tissue research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Daniel ShoupLaboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Hamilton, MT, 59840, USA.
Suzette A PriolaLaboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Hamilton, MT, 59840, USA. spriola@nih.gov.ORCID http://orcid.org/0000-0003-0303-3951
National Institutes of Health · US

Funding

Molecular Mechanisms of Prion Protein Amyloid FormationZIAAI001105 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI PRIOLA, SUZETTE ALISE · 2009 to 2025
$7.3M
MOLECULAR GENETICS OF SCRAPIE PATHOGENESISZ01AI000752 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI PRIOLA, SUZETTE ALISE · 1996 to 2008
$3.7M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases ZIA-AI000752-26Intramural NIH HHS Z01 AI000752
6 · The paper itself

Abstract

The properties of infectious prions and the pathology of the diseases they cause are dependent upon the unique conformation of each prion strain. How the pathology of prion disease correlates with different strains and genetic backgrounds has been investigated via in vivo assays, but how interactions between specific prion strains and cell types contribute to the pathology of prion disease has been dissected more effectively using in vitro cell lines. Observations made through in vivo and in vitro assays have informed each other with regard to not only how genetic variation influences prion properties, but also how infectious prions are taken up by cells, modified by cellular processes and propagated, and the cellular components they rely on for persistent infection. These studies suggest that persistent cellular infection results from a balance between prion propagation and degradation. This balance may be shifted depending upon how different cell lines process infectious prions, potentially altering prion stability, and how fast they can be transported to the lysosome. Thus, in vitro studies have given us a deeper understanding of the interactions between different prions and cell types and how they may influence prion disease phenotypes in vivo.

Indexed as

Prion DiseasesPrionsCell LineHumansPrionsCJDEndocytosisGAGSsGlycoseaminoglycanPrionPrion cell biologyPrPCPrPSc

Identifiers

PMID35107622
PMCPMC11249200
OpenAlexW4210553541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.